Results 231 to 240 of about 125,522 (281)

Cyclic GMP-independent induction of the cyclin-dependent kinase (Cdk) inhibitor p21SdiI/CipI/WafI by nitric oxide-generating agent in vascular smooth muscle cells

, 1998
Akio Ishida, Toshiyuki Sasaguri, Hiroshi Teruya, Yoji Taba, Yoshikazu Miwa   +4 more
openalex   +1 more source

Protocol for imaging and quantifying single-cell CDK activity levels during early mouse embryonic development by time-lapse microscopy. [PDF]

STAR Protoc
Saykali B, Tran AD, Kruhlak MJ, Ruiz S.
europepmc   +1 more source

Human CDC6/Cdc18 Associates with Orc1 and Cyclin-cdk and Is Selectively Eliminated from the Nucleus at the Onset of S Phase

, 1998
Partha Saha, Junjie Chen, Kelly C. Thome, Stephanie J. Lawlis, Zhihui Hou, Marvin Hendricks, Jeffrey D. Parvin, Anindya Dutta   +7 more
openalex   +2 more sources

Phytochemical profiling and anticancer activity of the n-butanol fraction from Ardisia villosa extract: Inhibition of gastric cancer cell proliferation via cell cycle arrest and senescence induction. [PDF]

PLoS One
Hua NM, Pham VK, Le TTH, Pham SH, Hoang V, Trinh TH, Can DQH, Hoang VH, Nguyen PH.   +8 more
europepmc   +1 more source

CDK inhibitory Proteins.

CDK inhibitory Proteins.
identifier:oai:t2r2.star.titech.ac.jp ...
openaire  

Cheminformatics Microservice V3: a web portal for chemical structure manipulation and analysis. [PDF]

J Cheminform
Rajan K, Chandrasekhar V, Sharma N, Kanakam SRS, Baensch F, Steinbeck C.   +5 more
europepmc   +1 more source

Evaluation of single-template ligand-based methods for the discovery of small-molecule nucleic acid binders. [PDF]

Brief Bioinform
Bajusz D, Rácz A, Bujnicki JM, Stefaniak F.   +3 more
europepmc   +1 more source

Repurposing Cofilin-Targeting Compounds for Ischemic Stroke Through Cheminformatics and Network Pharmacology. [PDF]

Pharmaceuticals (Basel)
Alaqel SI, Khan A, Alanazi MN, Nayeem N, Khaled HB, Imran M.   +5 more
europepmc   +1 more source

CDK12 and CDK13 in oncology: from RNA regulation to therapeutic targeting. [PDF]

Cell Oncol (Dordr)
Dudkiewicz-Garbicz J, Włodarski PK.
europepmc   +1 more source

The CDK inhibitor Roscovitine enhances the therapeutic efficacy of anti-PD-1 in non-small cell lung cancer. [PDF]

Front Oncol
Diaz-Montero CM, Holvey-Bates EG, Rayman PA, Parker Y, Lindner DJ, Stark GR, De S.   +6 more
europepmc   +1 more source